drugset / Trial / NCT00442559
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess real-world effectiveness of montelukast in children (2 to 14 years) with asthma and allergic rhinitis.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 4 mg | Oral |
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |